Prospective Comparison of Prognostic Scores in Palliative Care Cancer Populations

Author:

Maltoni Marco1,Scarpi Emanuela2,Pittureri Cristina3,Martini Francesca4,Montanari Luigi5,Amaducci Elena3,Derni Stefania4,Fabbri Laura4,Rosati Marta4,Amadori Dino6,Nanni Oriana2

Affiliation:

1. a Palliative Care Clinic, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola (FC), Italy;

2. b Biostatistics and Clinical Trials Unit, I.R.S.T., Meldola (FC), Italy;

3. c Palliative Care Unit, Savignano sul Rubicone Hospice, Savignano sul Rubicone (FC), Italy;

4. d Palliative Care Unit, Valerio Grassi Hospice, Forlimpopoli (FC), Italy;

5. e Palliative Care Unit, S. Domenico Hospice, Lugo (RA), Italy;

6. f Department of Medical Oncology, I.R.S.T., Meldola, Italy

Abstract

Abstract Purpose. Predicting prognosis in advanced cancer aids physicians in clinical decision making and can help patients and their families to prepare for the time ahead. Materials and Methods. This multicenter, observational, prospective, nonrandomized population-based study evaluated life span prediction of four prognostic scores used in palliative care: the original Palliative Prognostic Score (PaP Score), a variant of PaP Score including delirium (D-PaP Score), the Palliative Performance Scale, and the Palliative Prognostic Index. Results. A total of 549 patients were enrolled onto the study. Median survival of the entire group was 22 days (95% confidence intervals [95% CI] = 19–24). All four prognostic models discriminated well between groups of patients with different survival probabilities. Log-rank tests were all highly significant (p < .0001). The PaP and D-PaP scores were the most accurate, with a C index of 0.72 (95% CI = 0.70–0.73) and 0.73 (95% CI = 0.71–0.74), respectively. Conclusion. It can be confirmed that all four prognostic scores used in palliative care studies accurately identify classes of patients with different survival probabilities. The PaP Score has been extensively validated and shows high accuracy and reproducibility in different settings.

Funder

Istituto Oncologico Romagnolo

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3